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Other names: KIAA0042; HUMORFW; MGC142302 
Location: 1q32.1 
Local order:  Genes flanking KIF14 at 1q32.1 are 
(centromeric to telomeric): ZNF281 (zinc finger protein 




Gene spans 68.5 kbp on the minus strand at 1q32.1. 
Transcription 
One known 6586 base transcript, 30 exons. The KIF14 
promoter is bound by p130/ E2F4 under growth arrest 
conditions; further details of transcriptional regulation 
are currently lacking. 
Protein 
Description 
KIF14 is a 186 kDa, 1648 aa protein, containing 
kinesin motor and forkhead-associated (FHA) domains. 
It is a member of the N-3 family of kinesins. High-
throughput studies have identified phosphorylations  
Tyr-196; Ser-1200 and Ser-1292, and ubiquitination on 
Lys-275. 
Expression 
KIF14 was cloned from an immature myeloid cell line, 
KG-1. By qRT-PCR, KIF14 is expressed at low levels 
in normal adult tissues and at higher levels in placenta  
and fetal tissues; highest expression is in fetal thymus 
and liver. KIF14 expression varies with the cell cycle, 
with highest expression at G2-M. 
Localisation 
In HeLa cells, KIF14 is localized to the cytoplasm 
during interphase, and becomes tightly localized to the 
midbody and central spindle during cytokinesis. 
Function 
KIF14 is a mitotic kinesin motor protein with ATPase 
activity. It interacts with protein regulator of 
cytokinesis 1 (PRC1) and is essential for localizing 
citron kinase to the mitotic spindle. KIF14 knockdown 
results in failure of cytokinesis, leading to 
multinucleation and/or apoptosis, but no chromosome 
segregation defects. 
Homology 
There are KIF14 orthologs in several mammalian 
species. The closest Drosophila melanogaster gene, 
with 40% amino acid identity, is nebbish/tiovivo, 
encoding Klp38B (kinesin-like protein 38B). Klp38B is 
a mitotic kinesin that binds to chromatin and 
microtubules in the formation of the bipolar spindle and 




None yet identified. 
Somatic 
None yet identified. 
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Schematic representation of the KIF14 protein (not to scale). KIF14 contains two major effector domains. The first is a highly conserved 
274 aa kinesin motor domain containing an ATP-binding site (aa 447-454) which is involved in microtubule-dependent ATPase activity, 
and a microtubule binding site (aa 455-628) involved in ATP-dependent protein transport. The second is a 67 aa forkhead-associated 
(FHA) domain (aa 825-891) which has similarity to the SMAD Mad Homology 2 (MH2) domain, and is involved in mediating protein-
protein interactions with phosphoproteins, although no such interactions have been documented for KIF14. In addition to the highly 
conserved N-type neck region (N) adjacent to the motor domain, KIF14 also contains 4 other C-terminal regions predicted to form coiled-
coil structures (1-4). Phosphorylation sites have been identified on Tyr-196, Ser-1200 and Ser-1292 (P), and a ubiquitination site 
identified on Lys-275 (U). The kinesin motor and FHA domains are flanked by a 354 aa N-terminal extension, and a 758 aa C-terminal 
stalk and tail region. The N-terminal extension is involved in the binding of PRC1 (protein-regulating cytokinesis 1), a protein crucial for 
the proper formation of the central spindle structure during cytokinesis. Citron kinase has been shown to interact with the C-terminal 




KIF14 mRNA and protein expression is greatly 
increased in tumors versus normal adult and fetal 
retina. mRNA expression is higher in older patients' 
tumors than younger. 
Cytogenetics 
KIF14 lies in a 'hotspot' of genomic gain at 1q31.3-
1q32.1. Low-level genomic gain (3-5 copies) of the 
gene is observed in 50% of tumors. High-level 
amplification has been observed in one tumor (along 
with, but independent of, MYCN amplification). 
Breast carcinoma 
Prognosis 
mRNA expression increases with grade, and is higher 
in ductal than lobular carcinoma, and in estrogen 
receptor (ER) negative over ER positive tumors. 
Expression correlates with proliferation, and 
overexpression is prognostic for poor overall and 
disease-free survival. 
Cytogenetics 
KIF14 lies in a 'hotspot' of genomic gain at 1q31.3-
1q32.1. Low-level genomic gain of the gene is 
observed in 50% of breast cancer cell lines. 
Non-small-cell lung carcinoma 
Prognosis 
mRNA expression decreases with differentiation, and is 
higher in squamous cell than adenocarcinoma. 
Overexpression is independently prognostic for poor 
disease-free survival, and prognostic for poor overall 
survival. 
Oncogenesis 
Knockdown of KIF14 decreases proliferation of H1299 
NSCLC cells, and decreases their ability to form 
colonies in soft agar. 
Hepatocellular carcinoma 
Cytogenetics 
Low-level gain of the KIF14 locus is seen in 58% 
tumors. 
To be noted 
Note: Numerous microarray studies indexed in 
Oncomine document overexpression of KIF14 in other 
cancers, including brain tumors, seminoma, prostate 
and tongue cancers. 
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